Gabrielle M Haeusler
Overview
Explore the profile of Gabrielle M Haeusler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
886
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weerdenburg H, Walker H, Haeusler G, Cole T, Curtis N, Duffull S, et al.
J Antimicrob Chemother
. 2025 Mar;
PMID: 40037294
Background: Posaconazole is used to prevent and treat invasive fungal infections (IFIs) in immunocompromised children, including those undergoing cancer treatment or HSCT. Despite differences in pharmacokinetics and IFI epidemiology between...
2.
Phillips R, Fisher B, Ladas E, Patel P, Robinson P, Dupuis L, et al.
EClinicalMedicine
. 2025 Mar;
81:103093.
PMID: 40034572
Background: Food restrictions during periods of neutropenia have been widely used in oncology settings to prevent infections. As there is a lack of clearly demonstrated effectiveness, this strategy is being...
3.
Spotswood N, Grace E, Dargaville P, Beeson J, Hickey L, Haeusler G, et al.
Pediatr Infect Dis J
. 2025 Feb;
PMID: 39999389
Background: Antimicrobials are frequently prescribed to neonates who require hospital care, but the influences on clinical decision-making and practice variation in this process are ill-understood. We performed a cross-sectional survey...
4.
Eagling-Every E, Tsoi S, Walker H, Haeusler G
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31560.
PMID: 39865554
Chronic disseminated candidiasis (CDC) is a rare complication of immunosuppression. This review describes the presentation, management, and outcomes of CDC in pediatric patients with cancer or following hematopoietic cell transplant...
5.
Castagnola E, Bagnasco F, Mesini A, Agyeman P, Ammann R, Arrabito M, et al.
Antibiotics (Basel)
. 2025 Jan;
13(12.
PMID: 39766549
: Empirical antibacterial therapy for febrile neutropenia reduces mortality due to Gram-negative blood stream infections (BSIs). Pediatric guidelines recommend monotherapy with an antipseudomonal beta-lactam or a carbapenem and to add...
6.
Butters C, Grobler A, Rudkin A, Goh L, Werdenburg H, Hanna D, et al.
PLoS One
. 2024 Dec;
19(12):e0311523.
PMID: 39652544
In children with cancer, febrile neutropenia (FN) is one of the most common complications of treatment, a leading cause of unplanned and prolonged hospital admission and is the key driver...
7.
Haeusler G, Dashti S, James F, Babl F, Borland M, Clark J, et al.
Lancet Reg Health West Pac
. 2024 Nov;
53:101226.
PMID: 39553416
Background: Prompt antibiotic administration for febrile neutropenia (FN) is standard of care, and targets of time to antibiotics (TTA) <60 min are common. We sought to determine the effect of...
8.
Weerdenburg H, Gwee A, Haeusler G, Osowicki J, Boast A
J Antimicrob Chemother
. 2024 Oct;
79(12):3340-3343.
PMID: 39475156
Objectives: Therapeutic drug monitoring (TDM) is recommended for posaconazole to achieve target concentrations of ≥0.7 mg/L and ≥1.0 mg/L for prophylaxis and treatment of invasive fungal infection (IFI), respectively. However,...
9.
Zhu V, Horton M, Haeusler G, Yong M
Curr Opin Infect Dis
. 2024 Sep;
37(6):536-546.
PMID: 39331647
Purpose Of Review: Cytomegalovirus (CMV) infection is associated with severe clinical disease and high morbidity in immunocompromised hosts. Letermovir and maribavir, are two recently developed antiviral drugs used in the...
10.
Yeoh D, Blyth C, Clark J, Abbotsford J, Corrente C, Cook S, et al.
Lancet Reg Health West Pac
. 2024 Sep;
52:101201.
PMID: 39318715
Background: Invasive fungal disease (IFD) is a significant complication for children receiving treatment for leukaemia, contributing to morbidity and mortality. Recent regional paediatric epidemiological IFD data are lacking. Additionally uncertainty...